IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 81 a 100 di 104
Data di pubblicazione Titolo Autore(i) Tipo File
1-ago-2012 Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target Botti, E; Spallone, G; Caruso, R; Monteleone, G; Chimenti, S; Costanzo, A Articolo su rivista
1-set-2012 Cw6 but not allele LCE3C_LCE3B deletion confers sensitivity to ustekinumab treatment in psoriasis Botti, E; Talamonti, M; Spallone, G; Galluzzo, M; Bavetta, M; Teoli, M; Pinetti, V; Costanzo, A Intervento a convegno
1-set-2012 Next generation sequencing technology to explore anti-inflammatory activity of IKKa in psoriasis Spallone, G; Botti, E; Talamonti, M; Marinari, B; Pinetti, V; Chimenti, S; Costanzo, A Intervento a convegno
1-gen-2013 Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris Di Stefani, A; Galluzzo, M; Talamonti, M; Chiricozzi, A; Costanzo, A; Chimenti, S Articolo su rivista
1-gen-2013 Ustekinumab treatment of erythrodermic psoriasis occurring after physical stress: A report of two cases Saraceno, R; Talamonti, M; Galluzzo, M; Chiricozzi, A; Costanzo, A; Chimenti, S Articolo su rivista
1-gen-2013 Etanercept reverses downregulation of inhibitor of nuclear factor kappa-B kinase subunit alpha (IKKa) in psoriasis Spallone, G; Botti, E; Pinetti, V; Bavetta, M; Pavlidis, A; Chimenti, S; Costanzo, A Articolo su rivista
1-gen-2013 Potential role of HLA-Cw6 in clinical response to anti-tumour necrosis factor alpha and t-cell targeting agents in psoriasis patients Talamonti, M; Galluzzo, M; Botti, E; Pavlidis, A; Spallone, G; Chimenti, S; Costanzo, A Articolo su rivista
1-gen-2013 Genetic variations in IL6 and IL12B as protective markers for psoriasis Boca, An; Talamonti, M; Galluzzo, M; Botti, E; Buzoianu, Ad; Costanzo, A Intervento a convegno
1-mag-2013 Genetic variati ons in IL6 and IL12B as protecti ve markers for psoriasis Abstracts of the 2013 International Investigative Dermatology Meeting. May 8-11, 2013. Edinburgh, Scotland, United Kingdom Boca, A; Talamonti, M; Galluzzo, M; Botti, E; Buzoianu, A; Costanzo., A Intervento a convegno
1-gen-2014 Pharmacological treatment of androgenetic alopecia.Result of an observational study Carboni, I; Specchio, F; Costanzo, A; Nisticò, S Articolo su rivista
1-gen-2014 Human leucocyte antigen Cw6 predisposes to clinical response to the inlterleukin-12/23 blocker ustekinumab: results of long-term treatment Talamonti, M; Galluzzo, M; Botti, E; Chimenti, S; Costanzo, A Intervento a convegno
1-gen-2014 What happened after the clinical trials: Long-term safety and efficacy of ustekinumab in daily clinical practice Talamonti, M; Galluzzo, M; Bianchi, L; Boca, A; Costanzo, A; Chimenti, S Articolo su rivista
1-nov-2014 Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations Marinari, B; Botti, E; Bavetta, M; Spallone, G; Zangrilli, A; Talamonti, M; Richetta, A; Chimenti, S; Costanzo, A Articolo su rivista
1-gen-2016 Assessment of HLA Cw6 genotype and correlation to ustekinumab response in a large cohort of patients with moderate-to-severe psoriasis Talamonti, M; Galluzzo, M; Chimenti, S; Costanzo, A Intervento a convegno
1-gen-2016 HLA-C*06 and response to ustekinumab in Caucasian patients with psoriasis: Outcome and long-term follow-up Talamonti, M; Galluzzo, M; Chimenti, S; Costanzo, A Articolo su rivista
1-gen-2016 Label-free and non-invasive discrimination of HaCaT and melanoma cells in a co-culture model by hyperspectral confocal reflectance microscopy Bertani, Fr; Botti, E; Ferrari, L; Mussi, V; Costanzo, A; D'Alessandro, M; Cilloco, F; Selci, S Articolo su rivista
1-gen-2016 Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis Bessar, H; Venditti, I; Benassi, L; Vaschieri, C; Azzoni, P; Pellacani, G; Magnoni, C; Botti, E; Casagrande, V; Federici, M; Costanzo, A; Fontana, L; Testa, G; Mostafa, F; Ibrahim, S; Russo, M; Fratoddi, I Articolo su rivista
1-gen-2016 Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy Chiricozzi, A; Cannizzaro, M; Salandri, G; Marinari, B; Pitocco, R; Dattola, A; Regine, F; Saraceno, R; Bianchi, L; Chimenti, S; Costanzo, A Articolo su rivista
1-gen-2016 IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis Galluzzo, M; Boca, An; Botti, E; Potenza, C; Malara, G; Malagoli, P; Vesa, S; Chimenti, S; Buzoianu, Ad; Talamonti, M; Costanzo, A Articolo su rivista
1-gen-2018 Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey Potenza, Mc; Peris, K; Berardesca, E; Bianchi, L; Richetta, A; Bernardini, N; De Simone, C; Teoli, M; Zangrilli, A; D'Epiro, S; Orsini, D; Narcisi, A; Chimenti, S; Costanzo, A Articolo su rivista
Mostrati risultati da 81 a 100 di 104
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile